These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
396 related items for PubMed ID: 23664397
1. Combined diffusion-weighted, blood oxygen level-dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma. Notohamiprodjo M, Staehler M, Steiner N, Schwab F, Sourbron SP, Michaely HJ, Helck AD, Reiser MF, Nikolaou K. Acad Radiol; 2013 Jun; 20(6):685-93. PubMed ID: 23664397 [Abstract] [Full Text] [Related]
3. Diffusion-weighted intravoxel incoherent motion imaging of renal tumors with histopathologic correlation. Chandarana H, Kang SK, Wong S, Rusinek H, Zhang JL, Arizono S, Huang WC, Melamed J, Babb JS, Suan EF, Lee VS, Sigmund EE. Invest Radiol; 2012 Dec; 47(12):688-96. PubMed ID: 22996315 [Abstract] [Full Text] [Related]
4. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability. Braunagel M, Radler E, Ingrisch M, Staehler M, Schmid-Tannwald C, Rist C, Nikolaou K, Reiser MF, Notohamiprodjo M. Invest Radiol; 2015 Jan; 50(1):57-66. PubMed ID: 25260094 [Abstract] [Full Text] [Related]
8. Assessment of early therapeutic response to sorafenib in renal cell carcinoma xenografts by dynamic contrast-enhanced and diffusion-weighted MR imaging. Jeon TY, Kim CK, Kim JH, Im GH, Park BK, Lee JH. Br J Radiol; 2015 Sep; 88(1053):20150163. PubMed ID: 26133222 [Abstract] [Full Text] [Related]
10. Application of ADC measurement in characterization of renal cell carcinomas with different pathological types and grades by 3.0T diffusion-weighted MRI. Yu X, Lin M, Ouyang H, Zhou C, Zhang H. Eur J Radiol; 2012 Nov; 81(11):3061-6. PubMed ID: 22651905 [Abstract] [Full Text] [Related]
11. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. Xu PJ, Yan FH, Wang JH, Lin J, Ji Y. J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186 [Abstract] [Full Text] [Related]
16. Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma. Wehrli NE, Kim MJ, Matza BW, Melamed J, Taneja SS, Rosenkrantz AB. AJR Am J Roentgenol; 2013 Dec; 201(6):1260-7. PubMed ID: 24261365 [Abstract] [Full Text] [Related]
17. Comparison of utility of tumor size and apparent diffusion coefficient for differentiation of low- and high-grade clear-cell renal cell carcinoma. Maruyama M, Yoshizako T, Uchida K, Araki H, Tamaki Y, Ishikawa N, Shiina H, Kitagaki H. Acta Radiol; 2015 Feb; 56(2):250-6. PubMed ID: 24518687 [Abstract] [Full Text] [Related]
18. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings. Aydin H, Kizilgöz V, Tatar IG, Damar C, Ugan AR, Paker I, Hekimoğlu B. J Comput Assist Tomogr; 2012 Feb; 36(1):30-45. PubMed ID: 22261768 [Abstract] [Full Text] [Related]
19. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. Oto A, Yang C, Kayhan A, Tretiakova M, Antic T, Schmid-Tannwald C, Eggener S, Karczmar GS, Stadler WM. AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293 [Abstract] [Full Text] [Related]